Clinical Trial Update: Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports results for reduced-intensity conditioning and transplantation using HLA-haploidentical hematopoietic cell transplantation in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hematologic Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2025-05-28